{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:20:54Z","timestamp":1790713254649,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,1,31]],"date-time":"2008-01-31T00:00:00Z","timestamp":1201737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s10620-007-0148-z","type":"journal-article","created":{"date-parts":[[2008,1,29]],"date-time":"2008-01-29T23:21:45Z","timestamp":1201648905000},"page":"2556-2563","source":"Crossref","is-referenced-by-count":123,"title":["Fibrosis, Portal Hypertension, and Hepatic Volume Changes Induced by Intra-arterial Radiotherapy with 90Yttrium Microspheres"],"prefix":"10.1007","volume":"53","author":[{"given":"T. F.","family":"Jakobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Atassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Reda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Yaghmai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. K.","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. T.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. M.","family":"Kulik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Mulcahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Omary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Reiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,31]]},"reference":[{"issue":"4","key":"148_CR1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3322\/canjclin.49.4.202","volume":"49","author":"JS Macdonald","year":"1999","unstructured":"Macdonald JS (1999) Adjuvant therapy of colon cancer. CA Cancer J Clin 49(4):202\u2013219","journal-title":"CA Cancer J Clin"},{"issue":"16","key":"148_CR2","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","volume":"18","author":"A Gramont de","year":"2000","unstructured":"de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J et\u00a0al (2000) Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18(16):2938\u20132947","journal-title":"J Clin Oncol"},{"issue":"9209","key":"148_CR3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0140-6736(00)02034-1","volume":"355","author":"JY Douillard","year":"2000","unstructured":"Douillard JY, Cunningham D, Roth AD, Navarro M, James RD, Karasek P et\u00a0al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355(9209):1041\u20131047","journal-title":"Lancet"},{"issue":"2","key":"148_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","volume":"22","author":"C Tournigand","year":"2004","unstructured":"Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D et\u00a0al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22(2):229\u2013237","journal-title":"J Clin Oncol"},{"key":"148_CR5","doi-asserted-by":"crossref","unstructured":"Giantonio BJ, Catalano PJ, Meropol NJ, O\u2019Dwyer PJ, Mitchell EP, Alberts SR et\u00a0al (2007) Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the eastern cooperative oncology group study E3200. J Clin Oncol 25(12):1539\u20131544","DOI":"10.1200\/JCO.2006.09.6305"},{"key":"148_CR6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/1471-2407-7-91","volume":"7","author":"C Emmanouilides","year":"2007","unstructured":"Emmanouilides C, Sfakiotaki G, Androulakis N, Kalbakis K, Christophylakis C, Kalykaki A et\u00a0al (2007) Front-line bevacizumab in combination with oxaliplatin, leucovorin and 5-fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study. BMC Cancer 7:91","journal-title":"BMC Cancer"},{"issue":"11","key":"148_CR7","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1200\/JCO.2000.18.11.2210","volume":"18","author":"LA Dawson","year":"2000","unstructured":"Dawson LA, McGinn CJ, Normolle D, Ten Haken RK, Walker S, Ensminger W et\u00a0al (2000) Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies. J Clin Oncol 18(11):2210\u20132218","journal-title":"J Clin Oncol"},{"issue":"5","key":"148_CR8","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ijrobp.2004.09.004","volume":"60","author":"AS Kennedy","year":"2004","unstructured":"Kennedy AS, Nutting C, Coldwell D, Gaiser J, Drachenberg C (2004) Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys 60(5):1552\u20131563","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"148_CR9","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1007\/s00330-006-0508-7","volume":"17","author":"TF Jakobs","year":"2007","unstructured":"Jakobs TF, Hoffmann RT, Poepperl G, Schmitz A, Lutz J, Koch W et\u00a0al (2007) Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 17(5):1320\u20131330","journal-title":"Eur Radiol"},{"issue":"2","key":"148_CR10","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijrobp.2005.12.051","volume":"65","author":"AS Kennedy","year":"2006","unstructured":"Kennedy AS, Coldwell D, Nutting C, Murthy R, Wertman DE Jr, Loehr SP et\u00a0al (2006) Resin 90Y-microsphere brachytherapy for unresectable colorectal liver metastases: modern USA experience. Int J Radiat Oncol Biol Phys 65(2):412\u2013425","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"148_CR11","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","volume":"16","author":"RJ Lewandowski","year":"2005","unstructured":"Lewandowski RJ, Thurston KG, Goin JE, Wong CY, Gates VL, Van Buskirk M et\u00a0al (2005) 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135\u2013150\u00a0Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging. J Vasc Interv Radiol 16(12):1641\u20131651","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"148_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3748\/wjg.v9.i2.193","volume":"9","author":"LX Liu","year":"2003","unstructured":"Liu LX, Zhang WH, Jiang HC (2003) Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9(2):193\u2013200","journal-title":"World J Gastroenterol"},{"key":"148_CR13","doi-asserted-by":"crossref","unstructured":"Sharma RA, Van Hazel GA, Morgan B, Berry DP, Blanshard K, Price D et\u00a0al (2007) Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy. J Clin Oncol 25(9):1099\u20131106","DOI":"10.1200\/JCO.2006.08.7916"},{"issue":"2","key":"148_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","volume":"88","author":"G Hazel Van","year":"2004","unstructured":"Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G et\u00a0al (2004) Randomised phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 88(2):78\u201385","journal-title":"J Surg Oncol"},{"issue":"3","key":"148_CR15","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2007.03.056","volume":"69","author":"DM Coldwell","year":"2007","unstructured":"Coldwell DM, Kennedy AS, Nutting CW (2007) Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer. Int J Radiat Oncol Biol Phys 69(3):800\u2013804","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"148_CR16","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/jso.1162","volume":"78","author":"P Moroz","year":"2001","unstructured":"Moroz P, Anderson JE, Van Hazel G, Gray BN (2001) Effect of selective internal radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume. J Surg Oncol 78(4):248\u2013252","journal-title":"J Surg Oncol"},{"key":"148_CR17","doi-asserted-by":"crossref","unstructured":"Stubbs RS (2006) Portal hypertension and liver surgery following selective internal radiation therapy with 90Yttrium microspheres. J Clin Oncol 24(9):e15","DOI":"10.1200\/JCO.2005.05.2118"},{"issue":"1","key":"148_CR18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","volume":"68","author":"A Kennedy","year":"2007","unstructured":"Kennedy A, Nag S, Salem R, Murthy R, McEwan AJ, Nutting C et\u00a0al (2007) Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 68(1):13\u201323","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"148_CR19","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000164324.79242.B2","volume":"16","author":"DM Liu","year":"2005","unstructured":"Liu DM, Salem R, Bui JT, Courtney A, Barakat O, Sergie Z et\u00a0al (2005) Angiographic considerations in patients undergoing liver-directed therapy. J Vasc Interv Radiol 16(7):911\u2013935","journal-title":"J Vasc Interv Radiol"},{"issue":"9","key":"148_CR20","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG (2006) Radioembolization with 90yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 2: special topics. J Vasc Interv Radiol 17(9):1425\u20131439","journal-title":"J Vasc Interv Radiol"},{"issue":"8","key":"148_CR21","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","volume":"17","author":"R Salem","year":"2006","unstructured":"Salem R, Thurston KG (2006) Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: Technical and methodologic considerations. J Vasc Interv Radiol 17(8):1251\u20131278","journal-title":"J Vasc Interv Radiol"},{"issue":"10","key":"148_CR22","first-page":"1673","volume":"41","author":"JE Dancey","year":"2000","unstructured":"Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J et\u00a0al (2000) Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 41(10):1673\u20131681","journal-title":"J Nucl Med"},{"issue":"9 Pt 2","key":"148_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1051-0443(07)61790-4","volume":"13","author":"R Salem","year":"2002","unstructured":"Salem R, Thurston KG, Carr BI, Goin JE, Geschwind JF (2002) Yttrium-90 microspheres: radiation therapy for unresectable liver cancer. J Vasc Interv Radiol 13(9 Pt 2):223\u2013229","journal-title":"J Vasc Interv Radiol"},{"issue":"2 Pt 1","key":"148_CR24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.RVI.00001142592.89564.F9","volume":"16","author":"JE Goin","year":"2005","unstructured":"Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF et\u00a0al (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol 16(2 Pt 1):205\u2013213","journal-title":"J Vasc Interv Radiol"},{"issue":"3","key":"148_CR25","first-page":"293","volume":"24","author":"S Ho","year":"1997","unstructured":"Ho S, Lau WY, Leung TW, Chan M, Johnson PJ, Li AK (1997) Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer. Eur J Nucl Med 24(3):293\u2013298","journal-title":"Eur J Nucl Med"},{"issue":"8","key":"148_CR26","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","volume":"23","author":"S Ho","year":"1996","unstructured":"Ho S, Lau WY, Leung TW, Chan M, Ngar YK, Johnson PJ et\u00a0al (1996) Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 23(8):947\u2013952","journal-title":"Eur J Nucl Med"},{"issue":"4","key":"148_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00270-007-9064-z","volume":"30","author":"RJ Lewandowski","year":"2007","unstructured":"Lewandowski RJ, Sato KT, Atassi B, Ryu RK, Nemcek AA, Jr, Kulik L et\u00a0al (2007) Radioembolization with (90)y microspheres: angiographic and technical considerations. Cardiovasc Intervent Radiol 30(4):571\u2013592","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"4","key":"148_CR28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/0016-5085(86)90888-7","volume":"90","author":"JA Barnard","year":"1986","unstructured":"Barnard JA, Marshall GS, Neblett WW, Gray G, Ghishan FK (1986) Noncirrhotic portal fibrosis after Wilms\u2019 tumor therapy. Gastroenterology 90(4):1054\u20131056","journal-title":"Gastroenterology"},{"issue":"5","key":"148_CR29","first-page":"826","volume":"71","author":"R Phillips","year":"1954","unstructured":"Phillips R, Karnofsky DA, Hamilton LD, Nickson JJ (1954) Roentgen therapy of hepatic metastases. Am J Roentgenol Radium Ther Nucl Med 71(5):826\u2013834","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"148_CR30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2214\/ajr.117.1.73","volume":"117","author":"JT Wharton","year":"1973","unstructured":"Wharton JT, Delclos L, Gallager S, Smith JP (1973) Radiation hepatitis induced by abdominal irradiation with the cobalt 60 moving strip technique. Am J Roentgenol Radium Ther Nucl Med 117(1):73\u201380","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"2","key":"148_CR31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/hep.1840060212","volume":"6","author":"B Clement","year":"1986","unstructured":"Clement B, Grimaud JA, Campion JP, Deugnier Y, Guillouzo A (1986) Cell types involved in collagen and fibronectin production in normal and fibrotic human liver. Hepatology 6(2):225\u2013234","journal-title":"Hepatology"},{"issue":"1","key":"148_CR32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1600-0676.1988.tb00966.x","volume":"8","author":"Y Yokoi","year":"1988","unstructured":"Yokoi Y, Namihisa T, Matsuzaki K, Miyazaki A, Yamaguchi Y (1988) Distribution of Ito cells in experimental hepatic fibrosis. Liver 8(1):48\u201352","journal-title":"Liver"},{"key":"148_CR33","first-page":"200","volume":"93","author":"JA Ingold","year":"1965","unstructured":"Ingold JA, Reed GB, Kaplan HS, Bagshaw MA (1965) Radiation Hepatitis. Am J Roentgenol Radium Ther Nucl Med 93:200\u2013208","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"issue":"1","key":"148_CR34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2307\/3577063","volume":"115","author":"T Alati","year":"1988","unstructured":"Alati T, Van Cleeff M, Strom SC, Jirtle RL (1988) Radiation sensitivity of adult human parenchymal hepatocytes. Radiat Res 115(1):152\u2013160","journal-title":"Radiat Res"},{"issue":"1","key":"148_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510260117","volume":"26","author":"C Sempoux","year":"1997","unstructured":"Sempoux C, Horsmans Y, Geubel A, Fraikin J, Van Beers BE, Gigot JF et\u00a0al (1997) Severe radiation-induced liver disease following localized radiation therapy for biliopancreatic carcinoma: activation of hepatic stellate cells as an early event. Hepatology 26(1):128\u2013134","journal-title":"Hepatology"},{"issue":"1","key":"148_CR36","first-page":"21","volume":"96","author":"K Lewin","year":"1973","unstructured":"Lewin K, Millis RR (1973) Human radiation hepatitis. A morphologic study with emphasis on the late changes. Arch Pathol 96(1):21\u201326","journal-title":"Arch Pathol"},{"issue":"11","key":"148_CR37","first-page":"584","volume":"104","author":"LF Fajardo","year":"1980","unstructured":"Fajardo LF, Colby TV (1980) Pathogenesis of veno-occlusive liver disease after radiation. Arch Pathol Lab Med 104(11):584\u2013588","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"148_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02841860510007440","volume":"44","author":"LF Fajardo","year":"2005","unstructured":"Fajardo LF (2005) The pathology of ionizing radiation as defined by morphologic patterns. Acta Oncol 44(1):13\u201322","journal-title":"Acta Oncol"},{"issue":"4","key":"148_CR39","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1445-5994.2005.00789.x","volume":"35","author":"L Lim","year":"2005","unstructured":"Lim L, Gibbs P, Yip D, Shapiro JD, Dowling R, Smith D et\u00a0al (2005) Prospective study of treatment with selective internal radiation therapy spheres in patients with unresectable primary or secondary hepatic malignancies. Intern Med J 35(4):222\u2013227","journal-title":"Intern Med J"},{"issue":"8","key":"148_CR40","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/j.1445-2197.2006.03834.x","volume":"76","author":"RS Stubbs","year":"2006","unstructured":"Stubbs RS, O\u2019Brien I, Correia MM (2006) Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients. ANZ J Surg 76(8):696\u2013703","journal-title":"ANZ J Surg"},{"issue":"6","key":"148_CR41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00259-002-0787-4","volume":"29","author":"CY Wong","year":"2002","unstructured":"Wong CY, Salem R, Raman S, Gates VL, Dworkin HJ (2002) Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 29(6):815\u2013820","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"148_CR42","first-page":"1892","volume":"45","author":"CY Wong","year":"2004","unstructured":"Wong CY, Salem R, Qing F, Wong KT, Barker D, Gates V et\u00a0al (2004) Metabolic response after intraarterial 90Y-glass microsphere treatment for colorectal liver metastases: comparison of quantitative and visual analyses by 18F-FDG PET. J Nucl Med 45(11):1892\u20131897","journal-title":"J Nucl Med"},{"issue":"8","key":"148_CR43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1097\/01.RVI.0000168104.32849.07","volume":"16","author":"CY Wong","year":"2005","unstructured":"Wong CY, Qing F, Savin M, Campbell J, Gates VL, Sherpa KM et\u00a0al (2005) Reduction of metastatic load to liver after intraarterial hepatic yttrium-90 radioembolization as evaluated by [18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 16(8):1101\u20131106","journal-title":"J Vasc Interv Radiol"},{"issue":"4","key":"148_CR44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/cbr.2006.21.305","volume":"21","author":"CY Wong","year":"2006","unstructured":"Wong CY, Savin M, Sherpa KM, Qing F, Campbell J, Gates VL et\u00a0al (2006) Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma. Cancer Biother Radiopharm 21(4):305\u2013313","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"148_CR45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","volume":"22","author":"LD DeLeve","year":"2002","unstructured":"DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22(1):27\u201342","journal-title":"Semin Liver Dis"},{"issue":"6","key":"148_CR46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00007890-198706000-00020","volume":"43","author":"FL Dulley","year":"1987","unstructured":"Dulley FL, Kanfer EJ, Appelbaum FR, Amos D, Hill RS, Buckner CD et\u00a0al (1987) Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. Transplantation 43(6):870\u2013873","journal-title":"Transplantation"},{"issue":"4","key":"148_CR47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0889-8553(21)00228-4","volume":"24","author":"LD DeLeve","year":"1995","unstructured":"DeLeve LD, Kaplowitz N (1995) Mechanisms of drug-induced liver disease. Gastroenterol Clin North Am 24(4):787\u2013810","journal-title":"Gastroenterol Clin North Am"},{"issue":"3","key":"148_CR48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","volume":"15","author":"L Rubbia-Brandt","year":"2004","unstructured":"Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et\u00a0al (2004) Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15(3):460\u2013466","journal-title":"Ann Oncol"},{"issue":"6","key":"148_CR49","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2005.01.024","volume":"200","author":"FG Fernandez","year":"2005","unstructured":"Fernandez FG, Ritter J, Goodwin JW, Linehan DC, Hawkins WG, Strasberg SM (2005) Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases. J Am Coll Surg 200(6):845\u2013853","journal-title":"J Am Coll Surg"},{"issue":"13","key":"148_CR50","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","volume":"24","author":"JN Vauthey","year":"2006","unstructured":"Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM et\u00a0al (2006) Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24(13):2065\u20132072","journal-title":"J Clin Oncol"},{"issue":"7","key":"148_CR51","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11605-007-0149-4","volume":"11","author":"TM Pawlik","year":"2007","unstructured":"Pawlik TM, Olino K, Gleisner AL, Torbenson M, Schulick R, Choti MA (2007) Preoperative chemotherapy for colorectal liver metastases: impact on hepatic histology and postoperative outcome. J Gastrointest Surg 11(7):860\u2013868","journal-title":"J Gastrointest Surg"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-0148-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-007-0148-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-0148-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T23:27:57Z","timestamp":1630625277000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-007-0148-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,31]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["148"],"URL":"https:\/\/doi.org\/10.1007\/s10620-007-0148-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,31]]}}}